MTOR and prostate cancer: In this study, we found that miR-96 regulated autophagy in prostate cancer cells in a dose-dependent manner through directly targeting two critical autophagy-related factors, MTOR and ATG7. Both in vitro and in vivo results demonstrated that regulation of autophagy by miR-96 affected prostate cancer cell proliferation and tumor growth.